Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease

Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease

Abstract Background Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation, and is regarded as a key molecule driving immunotolerance and immunosuppressive mechanisms. Little is known about IDO activit...

Full description

Bibliographic Details
Main Authors: Nattawut Wongpraparut, Ploy Pengchata, Sudarat Piyophirapong, Pariya Panchavinnin, Rungtiwa Pongakasira, Noppadol Arechep, Kanda Kasetsinsombat, Kittipong Maneechotesuwan
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Indoleamine 2,3 dioxygenase level
IDO
Marker
Significant coronary artery disease
Online Access:https://doi.org/10.1186/s12872-021-02140-0

Internet

https://doi.org/10.1186/s12872-021-02140-0

Similar Items